NEW YORK (GenomeWeb News) – Oxford Gene Technology today announced it has licensed its patents for detecting DNA sequence variations to Biotype Diagnostics, which will use it to develop a microarray platform.
The rights are valid for the lifetime of the patents and give Biotype certain rights with respect to SNP genotyping, OGT said in a statement. Financial and other terms of the deal were not disclosed.
Wilhelm Zorgiebel, executive director for Dresden, Germany-based Biotype, said that the agreement "helps us to develop our own microarray technology platform for various applications in medicine and analytics."
He added that the firm intends to develop a microarray kit for simultaneous analysis of the 27 most important wood-rotting fungi in Europe.